Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

Similar articles for PubMed (Select 22912551)

1.

Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis.

Tonus C, Sellinger M, Koss K, Neupert G.

World J Gastroenterol. 2012 Aug 14;18(30):4004-11. doi: 10.3748/wjg.v18.i30.4004.

2.

Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohort.

Leen R, Seng-Lee C, Holleran G, O'Morain C, McNamara D.

Eur J Gastroenterol Hepatol. 2014 May;26(5):514-8. doi: 10.1097/MEG.0000000000000025.

PMID:
24699725
3.

A combination of faecal tests for the detection of colon cancer: a new strategy for an appropriate selection of referrals to colonoscopy? A prospective multicentre Italian study.

Parente F, Marino B, Ilardo A, Fracasso P, Zullo A, Hassan C, Moretti R, Cremaschini M, Ardizzoia A, Saracino I, Perna F, Vaira D.

Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1145-52. doi: 10.1097/MEG.0b013e328355cc79.

PMID:
22735608
4.

Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia.

Shastri YM, Naumann M, Oremek GM, Hanisch E, Rösch W, Mössner J, Caspary WF, Stein JM.

Int J Cancer. 2006 Dec 1;119(11):2651-6.

PMID:
16929517
5.

Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer.

Mulder SA, van Leerdam ME, van Vuuren AJ, Francke J, van Toorenenbergen AW, Kuipers EJ, Ouwendijk RJ.

Eur J Gastroenterol Hepatol. 2007 Oct;19(10):878-82.

PMID:
17873612
6.

Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study.

Haug U, Hundt S, Brenner H.

Br J Cancer. 2008 Jul 8;99(1):133-5. doi: 10.1038/sj.bjc.6604427. Epub 2008 Jun 10.

7.
8.

Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.

Kumar Y, Tapuria N, Kirmani N, Davidson BR.

Eur J Gastroenterol Hepatol. 2007 Mar;19(3):265-76. Review.

PMID:
17301655
9.
10.

Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer.

Hardt PD, Mazurek S, Toepler M, Schlierbach P, Bretzel RG, Eigenbrodt E, Kloer HU.

Br J Cancer. 2004 Aug 31;91(5):980-4.

11.

Comparison of an established simple office-based immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: prospective multicenter study.

Shastri YM, Loitsch S, Hoepffner N, Povse N, Hanisch E, Rösch W, Mössner J, Stein JM.

Am J Gastroenterol. 2008 Jun;103(6):1496-504. doi: 10.1111/j.1572-0241.2008.01824.x. Epub 2008 May 28.

PMID:
18510609
12.

The value of fecal tumor M2 pyruvate kinase as a diagnostic tool for colorectal cancer screening.

Abdullah M, Rani AA, Simadibrata M, Fauzi A, Syam AF.

Acta Med Indones. 2012 Apr;44(2):94-9.

13.

Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.

Haug U, Rothenbacher D, Wente MN, Seiler CM, Stegmaier C, Brenner H.

Br J Cancer. 2007 May 7;96(9):1329-34. Epub 2007 Apr 3.

14.

Fecal pyruvate kinase-M2 (tumor M2-PK) measurement: a new screening concept for colorectal cancer.

Ewald N, Schaller M, Bayer M, Akinci A, Bretzel RG, Kloer HU, Hardt PD.

Anticancer Res. 2007 Jul-Aug;27(4A):1949-52.

15.

Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK.

Tonus C, Neupert G, Sellinger M.

World J Gastroenterol. 2006 Nov 21;12(43):7007-11.

16.

Colon cancer screening: which non-invasive filter tests?

Pox C.

Dig Dis. 2011;29 Suppl 1:56-9. doi: 10.1159/000331127. Epub 2011 Nov 15. Review.

PMID:
22104755
17.

[Pyruvate kinase M2 (tumor M2-PK) as a screening tool for colorectal cancer (CRC). A review of current published data].

Ewald N, Toepler M, Akinci A, Kloer HU, Bretzel RG, Hardt PD.

Z Gastroenterol. 2005 Dec;43(12):1313-7. Review. German.

PMID:
16315127
18.

[Comparison of different stool tests for the detection of cancer of the colon].

Vogel T, Driemel C, Hauser A, Hansmann A, Lange S, Jonas M, Möslein G.

Dtsch Med Wochenschr. 2005 Apr 8;130(14):872-7. German.

PMID:
15800820
19.

Diagnostic value of fecal tumor M2-pyruvate kinase for CRC screening: a systematic review and meta-analysis.

Li R, Liu J, Xue H, Huang G.

Int J Cancer. 2012 Oct 15;131(8):1837-45. doi: 10.1002/ijc.27442. Epub 2012 Mar 8.

PMID:
22261915
20.

[Faecal pyruvate kinase type M2--a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study].

Naumann M, Schaum B, Oremek GM, Hanisch E, Rösch W, Mössner J, Caspary WF, Stein J.

Dtsch Med Wochenschr. 2004 Aug 20;129(34-35):1806-7. German. No abstract available.

PMID:
15314744
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk